(TVTX) Travere Therapeutics - Performance 90.2% in 12m
TVTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-21.01%
#44 in Peer-Group
Rel. Strength
92.79%
#554 in Stock-Universe
Total Return 12m
90.24%
#16 in Peer-Group
Total Return 5y
-26.99%
#43 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 23.75 USD |
| 52 Week Low | 7.89 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 41.17 |
| Buy/Sell Signal +-5 | 0.30 |
| Support / Resistance | Levels |
|---|---|
| Support | 13.4 |
| Resistance | 21.1, 20.0, 17.4 |
12m Total Return: TVTX (90.2%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: TVTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TVTX
| Total Return (including Dividends) | TVTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.38% | 3.36% | 5.25% |
| 3 Months | 0.13% | 15.73% | 24.13% |
| 12 Months | 90.24% | -7.02% | 14.15% |
| 5 Years | -26.99% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | TVTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.4% | 4.4% | 81% |
| 3 Months | -27.5% | 78.8% | 96.9% |
| 12 Months | 47.6% | -85.8% | 44.9% |
| 5 Years | -57.3% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th48.00 | -4.58% | -6.30% |
| 3 Month | %th29.50 | -13.48% | -19.33% |
| 12 Month | %th92.50 | 104.61% | 66.65% |
| 5 Years | %th78.00 | -3.67% | -65.54% |
FAQs
Does Travere Therapeutics (TVTX) outperform the market?
Yes,
over the last 12 months TVTX made 90.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months TVTX made 0.13%, while XBI made 15.73%.
Performance Comparison TVTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TVTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.1% | -6.6% | -25.4% | 76% |
| US NASDAQ 100 | QQQ | 0.1% | -6.7% | -26.1% | 78% |
| German DAX 40 | DAX | 2.1% | 0% | -37.6% | 61% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.1% | -4.6% | -28.9% | 70% |
| Hongkong Hang Seng | HSI | 0.3% | -7.4% | -44.9% | 52% |
| India NIFTY 50 | INDA | 1.8% | -4.9% | -25.8% | 91% |
| Brasil Bovespa | EWZ | -2.5% | -10.2% | -50.5% | 80% |
TVTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.3% | -7.3% | -29.6% | 66% |
| Consumer Discretionary | XLY | 0.4% | -4.6% | -17.8% | 72% |
| Consumer Staples | XLP | -0.4% | -2% | -27.1% | 81% |
| Energy | XLE | -0.4% | -8.4% | -21.3% | 90% |
| Financial | XLF | -0.8% | -6.5% | -30.4% | 60% |
| Health Care | XLV | 0.5% | -3.5% | -18.1% | 95% |
| Industrial | XLI | -0.2% | -5.6% | -33.3% | 65% |
| Materials | XLB | -2.3% | -5.7% | -30% | 84% |
| Real Estate | XLRE | -0% | -2.4% | -25.2% | 77% |
| Technology | XLK | -0.9% | -10.1% | -27.8% | 79% |
| Utilities | XLU | 1% | -3.2% | -28.7% | 67% |
| Aerospace & Defense | XAR | 2% | -8.4% | -44% | 41% |
| Biotech | XBI | -1.1% | -4.7% | -12.2% | 97% |
| Homebuilder | XHB | -2.6% | -8.4% | -18.3% | 85% |
| Retail | XRT | -2.6% | -6.4% | -21.1% | 79% |
TVTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1% | -9.82% | -17.1% | 98% |
| Natural Gas | UNG | 9.4% | 8.4% | -8.7% | 92% |
| Gold | GLD | -0.4% | -0.2% | -46.1% | 51% |
| Silver | SLV | -1.1% | -8.3% | -42.8% | 73% |
| Copper | CPER | 0.9% | -6% | -42.5% | 79% |
TVTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.7% | -2.4% | -22% | 92% |
| iShares High Yield Corp. Bond | HYG | 1.1% | -3% | -24.3% | 80% |